- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03057093
TIII Over TI in Subjects With Myocardial Infarction (T-infarction)
February 16, 2017 updated by: Dr. Fikret Er, University of Cologne
Assessment of T Wave Changes of Patients With Acute Non-ST-elevation Myocardial Infarction
Study was performed to identify ECG criteria for unmasking of subjects with NSTEMI at elevated risk.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In the present study the investigators assessed the value of T wave changes in subjects with NSTEMI (TIII>TI).
Study Type
Observational
Enrollment (Actual)
903
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Subjects with acute myocardial infarction without ST segment elevation
Description
Inclusion Criteria:
- NSTEMI and PCI
Exclusion Criteria:
- NSTEMI without percutaneous intervention
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
TIII>TI
Subjects with TIII>TI in initial ECG
|
retrospective noninterventional study
|
Non TIII>TI
Subjects without TIII>TI in initial ECG
|
retrospective noninterventional study
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Myocardial infarction size
Time Frame: 5 Days
|
Assessment of myocardial damage using biomarkers
|
5 Days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Correlation with coronary artery
Time Frame: 1 day
|
Assessment of association of infarct related artery and ECG changes
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2011
Primary Completion (Actual)
September 30, 2013
Study Completion (Actual)
January 15, 2017
Study Registration Dates
First Submitted
February 15, 2017
First Submitted That Met QC Criteria
February 16, 2017
First Posted (Actual)
February 17, 2017
Study Record Updates
Last Update Posted (Actual)
February 17, 2017
Last Update Submitted That Met QC Criteria
February 16, 2017
Last Verified
February 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Twave1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on NSTEMI - Non-ST Segment Elevation MI
-
Newcastle-upon-Tyne Hospitals NHS TrustNewcastle University; British Heart FoundationActive, not recruitingNSTEMI - Non-ST Segment Elevation MIUnited Kingdom
-
Assistance Publique - Hôpitaux de ParisAmgen; Action Research GroupRecruitingNSTEMI - Non-ST Segment Elevation MI | STEMI - ST Elevation Myocardial InfarctionFrance
-
Stony Brook UniversityHennepin County Medical Center, MinneapolisUnknownAcute Coronary Syndrome | STEMI | NSTEMI - Non-ST Segment Elevation MI | Non ST Segment Elevation Myocardial Infarction | Non-ST Elevation Myocardial Infarction | STEMI - ST Elevation Myocardial Infarction | Acute Coronary Artery Thrombosis (Diagnosis) | Non ST Segment Elevation Acute Coronary Syndrome and other conditionsUnited States
-
Marco MarchettiFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico; Abbott; Azienda Socio... and other collaboratorsCompleted
-
Azienda Ospedaliero Universitaria di SassariAstraZenecaCompletedST Elevation Myocardial Infarction | NSTEMI - Non-ST Segment Elevation MIItaly
-
Karolinska InstitutetCompletedNSTEMI - Non-ST Segment Elevation MI | STEMI - ST Elevation Myocardial InfarctionSweden
-
Charite University, Berlin, GermanyTerminatedAcute Coronary Syndrome | NSTEMI - Non-ST Segment Elevation MI | STEMI - ST Elevation Myocardial InfarctionGermany
-
Maastricht University Medical CenterVieCuri Medical CentreRecruitingNSTEMI - Non-ST Segment Elevation MI | ACS - Acute Coronary SyndromeNetherlands
-
IsalaCompletedCoronary Artery Disease | NSTEMI - Non-ST Segment Elevation MI | STEMI - ST Elevation Myocardial InfarctionNetherlands
-
Qilu Hospital of Shandong UniversityEnrolling by invitationNSTEMI - Non-ST Segment Elevation MI | Acute Heart Failure | Early ManagementChina
Clinical Trials on Non interventional study
-
Universitätsklinikum Hamburg-EppendorfSandozUnknownPsoriasisDenmark, Spain, Germany, Poland
-
University Hospital, RouenRecruitingDyspepsia | Irritable Bowel Syndrome | Functional Constipation | Faecal IncontinenceFrance
-
Mayo ClinicRecruitingOropharyngeal Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage III Oropharyngeal (p16-Negative)... and other conditionsUnited States
-
Mayo ClinicNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...RecruitingMalignant Solid Neoplasm | Hematopoietic and Lymphatic System NeoplasmUnited States
-
Mayo ClinicRecruitingStage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | Stage IIIA Bladder Cancer AJCC v8 | Stage II Bladder Cancer AJCC v8United States
-
Mayo ClinicRecruitingClear Cell Renal Cell Carcinoma | Urothelial Carcinoma | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Kidney Oncocytoma | Clear Cell Papillary Renal TumorUnited States
-
Mayo ClinicRecruitingProstate CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI); National Institute for Biomedical Imaging...RecruitingProstate NeoplasmUnited States
-
University of WashingtonNational Cancer Institute (NCI)RecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
Mayo ClinicRecruitingBreast CarcinomaUnited States